comparemela.com
Latest Breaking News On - James rossetti - Page 1 : comparemela.com
Myelofibrosis: Beyond Ruxolitinib
Other JAK inhibitors, combinations, and novel therapies offer more hope for patients
United-states
Texas
Massachusetts
Houston
American
James-rossetti
Mike-bassett
Naveen-pemmaraju
Hillman-cancer-center
University-of-texas-md-anderson-cancer-center
American-society-of-hematology
National-comprehensive-cancer-network
Myelofibrosis: More Than Meets the Eye?
Increased interest follows mutation discoveries, development of targeted therapies
United-states
Joe-lieberman
James-rossetti
Charles-bankhead
Gary-schiller
Hillman-cancer-center
University-of-california-los-angeles
University-of-pittsburgh
California-los
Hillman-cancer
Medpage-today
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management
Genetics already informs prognosis, may help guide therapy development beyond JAK2 inhibition
Philadelphia
Pennsylvania
United-states
Aaron-gerds
Gary-schiller
James-rossetti
Charles-bankhead
University-of-pittsburgh
University-of-california-los-angeles
California-los
Medpage-today
vimarsana © 2020. All Rights Reserved.